12:00 AM
Jun 25, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Rienso feraheme ferumoxytol regulatory update

The European Commission approved an MAA from Takeda for Rienso ferumoxytol to treat iron deficiency anemia in chronic kidney disease (CKD) patients. Takeda plans to launch the drug later this year....

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >